These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 34327414)

  • 1. An analysis of national action plans on antimicrobial resistance in Southeast Asia using a governance framework approach.
    Chua AQ; Verma M; Hsu LY; Legido-Quigley H
    Lancet Reg Health West Pac; 2021 Feb; 7():100084. PubMed ID: 34327414
    [TBL] [Abstract][Full Text] [Related]  

  • 2. National action plans on antimicrobial resistance in Latin America: an analysis via a governance framework.
    Avello P; Collins LM; Gómez SA; Luna F; Fernández Miyakawa ME; West HM; Iossa G
    Health Policy Plan; 2024 Feb; 39(2):188-197. PubMed ID: 38179856
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The global governance of antimicrobial resistance: a cross-country study of alignment between the global action plan and national action plans.
    Munkholm L; Rubin O
    Global Health; 2020 Nov; 16(1):109. PubMed ID: 33176810
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Measuring the global response to antimicrobial resistance, 2020-21: a systematic governance analysis of 114 countries.
    Patel J; Harant A; Fernandes G; Mwamelo AJ; Hein W; Dekker D; Sridhar D
    Lancet Infect Dis; 2023 Jun; 23(6):706-718. PubMed ID: 36657475
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessing transparency and accountability of national action plans on antimicrobial resistance in 15 African countries.
    Harant A
    Antimicrob Resist Infect Control; 2022 Jan; 11(1):15. PubMed ID: 35073967
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Qualitative Study on the Design and Implementation of the National Action Plan on Antimicrobial Resistance in the Philippines.
    Lota MMM; Chua AQ; Azupardo K; Lumangaya C; Reyes KAV; Villanueva SYAM; Legido-Quigley H; Roxas EA
    Antibiotics (Basel); 2022 Jun; 11(6):. PubMed ID: 35740226
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Benchmarking national action plans on antimicrobial resistance in eight selected LMICs: Focus on the veterinary sector strategies.
    Samuel F Orubu E; Sutradhar I; Zaman MH; Wirtz VJ
    J Glob Health; 2020 Dec; 10(2):020414. PubMed ID: 33110576
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A review of national action plans on antimicrobial resistance: strengths and weaknesses.
    Willemsen A; Reid S; Assefa Y
    Antimicrob Resist Infect Control; 2022 Jun; 11(1):90. PubMed ID: 35739564
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Attention to the Tripartite's one health measures in national action plans on antimicrobial resistance.
    Munkholm L; Rubin O; Bækkeskov E; Humboldt-Dachroeden S
    J Public Health Policy; 2021 Jun; 42(2):236-248. PubMed ID: 33597731
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A governance framework for development and assessment of national action plans on antimicrobial resistance.
    Anderson M; Schulze K; Cassini A; Plachouras D; Mossialos E
    Lancet Infect Dis; 2019 Nov; 19(11):e371-e384. PubMed ID: 31588040
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Governance and Implementation of the National Action Plan on Antimicrobial Resistance in Tanzania: A Qualitative Study.
    Frumence G; Mboera LEG; Sindato C; Katale BZ; Kimera S; Metta E; Durrance-Bagale A; Jung AS; Mshana SE; Clark TG; Rweyemamu M; Legido-Quigley H; Matee MIN
    Antibiotics (Basel); 2021 Mar; 10(3):. PubMed ID: 33803077
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Closing the GAP in Antimicrobial Resistance Policy in Benin and Burkina Faso.
    Sariola S; Butcher A; Cañada JA; Aïkpé M; Compaore A
    mSystems; 2022 Aug; 7(4):e0015022. PubMed ID: 35894597
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An analysis of existing national action plans for antimicrobial resistance-gaps and opportunities in strategies optimising antibiotic use in human populations.
    Charani E; Mendelson M; Pallett SJC; Ahmad R; Mpundu M; Mbamalu O; Bonaconsa C; Nampoothiri V; Singh S; Peiffer-Smadja N; Anton-Vazquez V; Moore LSP; Schouten J; Kostyanev T; Vlahović-Palčevski V; Kofteridis D; Corrêa JS; Holmes AH
    Lancet Glob Health; 2023 Mar; 11(3):e466-e474. PubMed ID: 36739875
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Coming of age: governance challenges in updated AMR national action plans in the EU.
    Carelli DE; Ogne JB; Pierre J
    Eur J Public Health; 2024 Oct; 34(5):885-889. PubMed ID: 38578613
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antimicrobial resistance in China across human, animal, and environment sectors - a review of policy documents using a governance framework.
    Yang D; Dyar OJ; Yin J; Ma W; Sun Q; Lundborg CS
    Lancet Reg Health West Pac; 2024 Jul; 48():101111. PubMed ID: 38948912
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparative assessment of action plans on antimicrobial resistance from OECD and G20 countries using natural language processing.
    Özçelik EA; Doucet C; Kang H; Levy N; Feldhaus I; Hashiguchi TCO; Lerouge A; Cecchini M
    Health Policy; 2022 Jun; 126(6):522-533. PubMed ID: 35379524
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antimicrobial resistance control efforts in Africa: a survey of the role of Civil Society Organisations.
    Fraser JL; Alimi YH; Varma JK; Muraya T; Kujinga T; Carter VK; Schultsz C; Del Rio Vilas VJ
    Glob Health Action; 2021 Jan; 14(1):1868055. PubMed ID: 33475046
    [No Abstract]   [Full Text] [Related]  

  • 18. Moving from assessments to implementation: promising practices for strengthening multisectoral antimicrobial resistance containment capacity.
    Joshi MP; Alombah F; Konduri N; Ndiaye A; Kusu N; Kiggundu R; Lusaya EP; Tuala Tuala R; Embrey M; Hafner T; Traore O; Mbaye M; Akinola B; Namburete D; Acho A; Hema Y; Getahun W; Sayem MA; Nfor E
    One Health Outlook; 2023 Apr; 5(1):7. PubMed ID: 37055845
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of a cross-sectoral antimicrobial resistance capability assessment framework.
    Ferdinand AS; McEwan C; Lin C; Betham K; Kandan K; Tamolsaian G; Pugeva B; McKenzie J; Browning G; Gilkerson J; Coppo M; James R; Peel T; Levy S; Townell N; Jenney A; Stewardson A; Cameron D; Macintyre A; Buising K; Howden BP
    BMJ Glob Health; 2024 Jan; 9(1):. PubMed ID: 38232993
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.